GNI GROUP LTD.
Personal information protection policy
Terms of Use
Site Map
Career
Japanese
Top Page
About Us
R&D
Investor Relations
Contact Us
[Link to Japanese page]
Latest Information
Read more
06/29/2023
Information
Q&A of Cullgen and Astellas’ Collaboration Agreement
05/25/2023
Information
Notice of maintenance and upgrade of our website
IR News
Read more
About Us
Message
Business Model/Business Overview
Board of Directors
Company Overview
Office
Corporate governance
R&D
R&D
Products/Pipeline
艾思瑞
®
(ETUARY)
F351
F573
Tamibarotene
Discovery Research
Interstitial Lung Disease
Liver disease area
Chronic kidney disease (CKD or CRD)
Research publications
Investor Relations
IR News
Message
Stock Quote
